Theravance Biopharma (TBPH) Asset Utilization Ratio (2014 - 2026)
Theravance Biopharma's (TBPH) Asset Utilization Ratio stood at 0.22 in Q2 2026, up 10.4% from 0.20 a year earlier but down 3.4% from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Asset Utilization Ratio (2014 - 2026) Analysis & Trends
For FY2025, Theravance Biopharma's Asset Utilization Ratio came in at 0.26, up 46.3% from FY2024.
- Annual Asset Utilization Ratio has increased for three straight years.
- Across earlier years, Asset Utilization Ratio came in at 0.17 in FY2024 (+50.7%), 0.12 in FY2023 (+11.0%), 0.10 in FY2022 (-20.2%) and 0.13 in FY2021 (-19.9%).
- Quarterly Asset Utilization Ratio has ranged from 0.07 in Q4 2022 to 0.24 in Q4 2025 over the past five years.
- On a year-over-year basis, Asset Utilization Ratio has increased for 12 consecutive quarters, with growth averaging 21.3% over the last eight quarters.
- Peak year-over-year performance for Asset Utilization Ratio in the last five years was growth of 92.7% in Q4 2023, against a decline of 47.3% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 0.23 (Q1 2026), 0.24 (Q4 2025) and 0.19 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 0.47 |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | 0.22 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.22 |
| Mar 31, 2026 | 0.23 |
| Dec 31, 2025 | 0.24 |
| Sep 30, 2025 | 0.19 |
| Jun 30, 2025 | 0.20 |
| Mar 31, 2025 | 0.19 |
| Dec 31, 2024 | 0.18 |
| Sep 30, 2024 | 0.18 |
| Jun 30, 2024 | 0.17 |
| Mar 31, 2024 | 0.16 |
| Dec 31, 2023 | 0.14 |
| Sep 30, 2023 | 0.13 |
| Jun 30, 2023 | 0.10 |
| Mar 31, 2023 | 0.08 |
| Dec 31, 2022 | 0.07 |
| Sep 30, 2022 | 0.09 |
| Jun 30, 2022 | 0.15 |
| Mar 31, 2022 | 0.15 |
| Dec 31, 2021 | 0.14 |
| Sep 30, 2021 | 0.14 |
API Access
Theravance Biopharma Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();